|
1.
|
2023/06/06
|
|
A single-blind, randomized, crossover study on the efficacy of icatibant for sweating-induced dermal pain (icatibant for sweating-induced dermal pain)
|
|
2.
|
2023/05/14
|
|
Positron emission tomography and computed tomography imaging in primary cutaneous nocardiosis with osteomyelitis clinically mimicking soft tissue sarcoma
|
|
3.
|
2023/04/17
|
|
Dramatic deterioration or new-onset dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid after COVID-19 vaccination: A possible manifestation of immune reconstitution inflammatory syndrome
|
|
4.
|
2023/01
|
|
Intravenous immunoglobulin in patients with bullous pemphigoid insufficient response to corticosteroids: Nationwide post-marketing surveillance in Japan.
|
|
5.
|
2022/12/28
|
|
SARS‐CoV‐2 vaccine‐triggered conversion from systemic lupus erythematosus (SLE) to bullous SLE and dipeptidyl peptidase 4 inhibitors‐associated bullous pemphigoid
|
|
6.
|
2022/07
|
|
Clinical features of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid in Japan: A nationwide retrospective observational study.
|
|
7.
|
2022/06
|
|
Anhidrosis accompanied by cholinergic urticaria-like rash and dermal pain in a patient with Sjögren's syndrome
|
|
8.
|
2022/06
|
|
Anti-Cytomegalovirus Therapy: Whether and When to Initiate, Those Are the Questions
|
|
9.
|
2022/06
|
|
Neutrophil to lymphocyte ratio is predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: A retrospective longitudinal observational study
|
|
10.
|
2021/11
|
|
Risk of progression to autoimmune disease in severe drug eruption: risk factors and the factor-guided stratification
|
|
11.
|
2021/10/01
|
|
Role of proinflammatory cytokines in the pathophysiology of herpes simplex virus superinfection in Darier disease
|
|
12.
|
2021/10
|
|
Role of pro-inflammatory cytokines in the pathophysiology of herpes simplex virus superinfection in Darier's disease.
|
|
13.
|
2021/09
|
|
A multicenter, open-label, uncontrolled, single-arm phase 2 study of tirabrutinib, an oral Bruton's tyrosine kinase inhibitor, in pemphigus.
|
|
14.
|
2021/07
|
|
2020 guidelines for the diagnosis and treatment of cutaneous pruritus.
|
|
15.
|
2021/04/14
|
|
Granular C3 dermatosis: Report of a case resembling dermatophytid in association with tinea pedis
|
|
16.
|
2021/04
|
|
Gender disparities in academic dermatology in Japan: Results from the first national survey.
|
|
17.
|
2021/02
|
|
Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation
|
|
18.
|
2021/01/13
|
|
Risk factors for cytomegalovirus reactivation in autoimmune bullous disease patients on immunosuppressive therapy
|
|
19.
|
2021/01
|
|
Gender disparities in academic dermatology in Japan: Results from the first national survey
|
|
20.
|
2021/01
|
|
Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report
|
|
21.
|
2020/11
|
|
Genome-wide association study identifies CDH13 as a susceptibility gene for rhododendrol-induced leukoderma
|
|
22.
|
2020/09/30
|
|
Hypercalcemia Associated with Extramammary Paget's Disease
|
|
23.
|
2020/09/17
|
|
Detection of multinucleated giant cells in differentiated keratinocytes with herpes simplex virus and varicella zoster virus infections by modified Tzanck smear method
|
|
24.
|
2020/08/15
|
|
Folliculotropic mycosis fungoides treated with electron beam therapy that evolved into fatal, tumor-stage mycosis fungoides and erythroderma with multiple ulcerations
|
|
25.
|
2019/12
|
|
Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)
|
|
26.
|
2019/11
|
|
NGS-based targeted resequencing identified rare subtypes of albinism: Providing accurate molecular diagnosis for Japanese patients with albinism.
|
|
27.
|
2019/10/24
|
|
Committee for Guidelines for the Management of Pemphigoid Diseases
(Including Epidermolysis Bullosa Acquisita). Japanese guidelines for the
management of pemphigoid (including epidermolysis bullosa acquisita).
|
|
28.
|
2019/09
|
|
Prurigo nodularis as a sweat gland/duct-related disorder: resolution associated with restoration of sweating disturbance.
|
|
29.
|
2019/07
|
|
Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma.
|
|
30.
|
2019/04
|
|
Corticosteroid-resistant prurigo nodularis: a rare syringotropic variant associated with hypohidrosis
|
|
31.
|
2019/04
|
|
Postherpetic hypohidrosis-related isotopic response associated with lichen planus and lichen amyloidosis.
|
|
32.
|
2019/02
|
|
Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open-label, single-arm, phase 1/2 study on 10 Japanese patients.
|
|
33.
|
2019/01
|
|
Cell-to-cell transmission of HSV-1 in differentiated keratinocytes promotes multinucleated giant cell formation.
|
|
34.
|
2019/01
|
|
Drug fever and acute inflammation from hypercytokinemia triggered by dipeptidyl peptidase-4 inhibitor vildagliptin.
|
|
35.
|
2018/11
|
|
Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP.
|
|
36.
|
2018/10
|
|
Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome.
|
|
37.
|
2018/10
|
|
Sweat is a most efficient natural moisturizer providing protective immunity at points of allergen entry.
|
|
38.
|
2018/09
|
|
Results of a nationwide epidemiologic survey of autosomal recessive congenital ichthyosis and ichthyosis syndromes in Japan.
|
|
39.
|
2018/05
|
|
Sterol profiles are valuable biomarkers for phenotype expression of Conradi-Hunermann-Happle syndrome with EBP mutations.
|
|
40.
|
2018/01
|
|
Immune reconstitution inflammatory syndrome in non-HIV immunosuppressed patients.
|
|
41.
|
2018/01
|
|
Local desensitization and progression of multiple fixed drug eruption.
|
|
42.
|
2017/12
|
|
A novel IFIH1 mutation in the pincer domain underlies the clinical features of both Aicardi-Goutieres and Singleton-Merten syndromes in a single patient.
|
|
43.
|
2017/09
|
|
A three-dimensional strain measurement method in elastic transparent materials using tomographic particle image velocimetry.
|
|
44.
|
2017/08
|
|
An unusual clinical presentation of lupus erythematosus tumidus localized on the thigh.
|
|
45.
|
2017/07
|
|
Multiple drug sensitization syndrome: A distinct phenotype associated with unrecognized Mycoplasma pneumonia infection.
|
|
46.
|
2017/07
|
|
Prediction and management of drug reaction with eosinophilia and systemic symptoms (DRESS).
|
|
47.
|
2017/05
|
|
Lichen amyloidosus as a sweat gland/duct-related disorder: resolution associated with restoration of sweating disturbance.
|
|
48.
|
2017/05
|
|
Phenotypic analysis of circulating T-cell subset and its association with burden of skin disease in patients with chronic actinic dermatitis: a hematologic and clinicopathologic study of 20 subjects.
|
|
49.
|
2017/02
|
|
A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid.
|
|
50.
|
2017/01
|
|
Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations.
|
|
51.
|
2016/12
|
|
Analysis of human leukocyte antigen genotypes in pemphigus with antidesmoglein antibody profile shift
|
|
52.
|
2016/12
|
|
Delayed timing of lymphocyte activation in vitro in lamotrigine-induced hypersensitivity syndrome.
|
|
53.
|
2016/11
|
|
A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid.
|
|
54.
|
2016/11
|
|
Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms.
|
|
55.
|
2016/09
|
|
Management of erythematous skin lesions in bullous pemphigoid associated with atopic dermatitis.
|
|
56.
|
2016/07
|
|
Long-lasting Localized Pemphigus Vulgaris without Detectable Serum Autoantibodies Against Desmoglein 3 and Desmoglein 1.
|
|
57.
|
2016/04
|
|
Atypical pemphigus with immunoglobulin G autoantibodies against desmoglein 3 and desmocollin 3.
|
|
58.
|
2016/02
|
|
Possible enhancement of BP180 autoantibody production by herpes zoster.
|
|
59.
|
2016/01
|
|
Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages.
|
|
60.
|
2015/08
|
|
Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
|
|
61.
|
2015/08
|
|
Monitoring the acute response in severe hypersensitivity reactions to drugs.
|
|
62.
|
2015/07
|
|
Annular pustular psoriasis with a heterozygous IL36RN mutation.
|
|
63.
|
2015/04
|
|
Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid.
|
|
64.
|
2015/03
|
|
Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
|
|
65.
|
2015/02
|
|
Guide for medical professionals (i.e., dermatologists) for the management of Rhodode
|
|
66.
|
2015
|
|
Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests.
|
|
67.
|
2015
|
|
Detection of autoantibodies against the calcium-dependent epitopes of desmoglein 3 by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with mammalian cell expression systems.
|
|
68.
|
2015
|
|
Necrobiotic features in both cutaneous and lymph node lesions in a patient with interstitial mycosis fungoides.
|
|
69.
|
2015
|
|
Treatment of a patient with neutrophilic dermatosis with granulocyte and monocyte adsorption apheresis: effects on serum cytokine levels
|
|
70.
|
2014/11
|
|
Increase of DC-LAMP+ mature dendritic cell subsets in dermatopathic lymphadenitis of mycosis fungoides.
|
|
71.
|
2014/05
|
|
A typical case of paraneoplastic pemphigus without detection of malignancy: effectiveness of plasma exchange.
|
|
72.
|
2014
|
|
Detection of Autoantibodies to Precursor Proteins of Desmogleins in Sera of a Patient with Bowen Carcinoma.
|
|
73.
|
2014
|
|
DNAX-activating Protein 10 (DAP10) Membrane Adaptor Associates with Receptor for Advanced Glycation End Products (RAGE) and Modulates the RAGE-triggered Signaling Pathway in Human Keratinocytes.
|
|
74.
|
2014
|
|
Grading criteria for disease severity by pemphigus disease area index
|
|
75.
|
2014
|
|
Herpes simplex virus reactivation as a trigger of mucous lesions in pemphigus vulgaris.
|
|
76.
|
2014
|
|
High Anti-Desmoglein 3 Antibody ELISA Index and Negative Indirect Immunofluorescence Result in a Patient With Pemphigus Vulgaris in Remission: Evaluation of the Antibody Profile by Newly Developed Methods.
|
|
77.
|
2014
|
|
Japanese guidelines for the management of pemphigus.
|
|
78.
|
2014
|
|
Novel TGM1 Missense Mutation p.Arg727Gln in a Case of Self-healing Collodion Baby.
|
|
79.
|
2013/09
|
|
Methylprednisolone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis: Clinical evaluation and analysis of biomarkers
|
|
80.
|
2013/07
|
|
Collapse of the keratin filament network through the expression of mutant keratin 6c observed in a case of focal plantar keratoderma.
|
|
81.
|
2013/06
|
|
Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
|
|
82.
|
2013/03
|
|
Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway.
|
|
83.
|
2013/01
|
|
Successful therapeutic use of targeted narrow-band ultraviolet B therapy for refractory Hailey-Hailey disease.
|
|
84.
|
2013
|
|
A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris.
|
|
85.
|
2013
|
|
Granulocyte colony-stimulating factorproducing squamous cell carcinoma of the skin associated with epithelial-messen-chymal transition.
|
|
86.
|
2013
|
|
Novel ABCA12 missense mutation p.Phe2144Ser underlies congenital ichthyosiform erythroderma
|
|
87.
|
2013
|
|
Successful Therapeutic Use of Targeted Narrow-band Ultraviolet B Therapy for Refractory Hailey-Hailey Disease.
|
|
88.
|
2012/11
|
|
Eccrine poromatosis associated with polychemotherapy.
|
|
89.
|
2012/01
|
|
Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands.
|
|
90.
|
2012
|
|
Detection of antibodies against the non-calcium-dependent epitopes of desmoglein 3 in pemphigus vulgaris and their pathogenic significance
|
|
91.
|
2012
|
|
Epidemiology and clinical characteristics of bullous congenital ichthyosiform erythroderma (keratinolytic ichthyosis) in Japan: results from a nationwide survey.
|
|
92.
|
2012
|
|
Overexpression of monocyte chemoattractant protein-1 in the overlying epidermis of multicentric reticulohistiocytosis lesions: a case report.
|
|
93.
|
2012
|
|
T(H)2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis.
|
|
94.
|
2011/09
|
|
Two cases of recessive dystrophic epidermolysis bullosa diagnosed as severe generalized.
|
|
95.
|
2011/07
|
|
Human leukocyte antigen genotypes and antibody profiles associated with familial
pemphigus in Japanese.
|
|
96.
|
2011
|
|
Catabolism of pemphigus foliaceus autoantibodies by high-dose IVIg therapy: a case study.
|
|
97.
|
2011
|
|
New insight into genotype/phenotype correlations in ABCA12 mutations in harlequin ichthyosis.
|
|
98.
|
2011
|
|
Two cases of Recessive Dystrophic Epidermolysis Bullosa diagnosed as severe Generalized.
|
|
99.
|
2010/10
|
|
New non-invasive method for evaluation of the stratum corneum structure in diseases with abnormal keratinization by immunofluorescence microscopy of desmoglein 1 distribution in tape-stripped samples.
|
|
100.
|
2010/03
|
|
What's new in i.v. immunoglobulin therapy and pemphigus: high-dose i.v. immunoglobulin therapy and its mode of action for treatment of pemphigus.
|
|
101.
|
2010
|
|
A new non-invasive method for evaluation of the stratum corneum structure in diseases with abnormal keratinization by immunofluorescence microscopy of desmoglein 1 distribution in tape-stripped samples.
|
|
102.
|
2010
|
|
Binding of pemphigus-vulgaris IgG to antigens in desmosome core domains excludes immune-complexes rather than directly splitting desmosomes.
|
|
103.
|
2010
|
|
Dynamic relationship of focal contacts and hemidesmosome protein complexes in live cells.
|
|
104.
|
2010
|
|
Human leukocyte antigen genotypes and antibody profiles associated with familial pemphigus in Japanese.
|
|
105.
|
2009
|
|
A case of anti-p200 pemphigoid; evidence for a different pathway in neutrophil recruitment compared to bullous pemphigoid.
|
|
106.
|
2009
|
|
Generalized eruption with histopathologic toxic epidermal necrolysis caused by occupational exposure to thiourea dioxide.
|
|
107.
|
2009
|
|
IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachmenet.
|
|
108.
|
2009
|
|
Low to high Ca2+-switch causes phosphorylation and association of desmocollin 3 with plakoglobin and desmoglein 3 in cultured keratinocytes.
|
|
109.
|
2009
|
|
Spindle cell squamous cell carcinoma showing epithelial-mesenchymal transition.
|
|
110.
|
2009
|
|
Subcutaneous phaeohyphomycosis caused by Exophiala xenobiotica in a non-Hodgkin lymphoma patient.
|
|
111.
|
2008/09
|
|
Severe pemphigus vulgaris: successful combination therapy of plasmapheresis followed by intravenous high-dose immunoglobulin to prevent rebound increase in pathogenic IgG.
|
|
112.
|
2008
|
|
p120 catenin is associated with desmogleins when desmosomes are assembled in high-Ca2+ medium but not when disassembled in low-Ca2+ medium in DJM-1 cells.
|
|
113.
|
2008
|
|
p120-catenin is a novel desmoglein 3 interacting partner: identification of the p120-catenin association site of desmoglein 3.
|
|
114.
|
2007
|
|
Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity.
|
|
115.
|
2007
|
|
Cicatricial pemphigoid with prominent alopecia.
|
|
116.
|
2007
|
|
Herpes gestationis in a mother and newborn: immunoclinical perspectives based on a weekly follow-up of the enzyme-linked immunosorbent assay index of a bullous pemphigoid antigen noncollagenous domain.
|
|
117.
|
2007
|
|
Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
|
|
118.
|
2007
|
|
No activation of urokinase plasminogen activator by anti-desmoglein 3 monoclonal IgG antibodies in cultured human keratinocytes.
|
|
119.
|
2007
|
|
Ten novel mutations of the ADAR1 gene in Japanese patients with dyschromatosis symmetrica hereditaria.
|
|
120.
|
2006
|
|
Pathogenic monoclonal antibody against desmoglein 3 augments desmoglein 3 and p38 MAPK phosphorylation in human squamous carcinoma cell line.
|
|
121.
|
2005
|
|
Pemphigus vulgaris-IgG reduces the desmoglein 3/desmocollin 3 ratio on the cell surface in cultured keratinocytes as revealed by double-staining immunoelectron microscopy.
|
|
122.
|
2004
|
|
Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases.
|
|
123.
|
2003
|
|
A mitotic cascade of NIMA family kinases. Nercc1/Nek9 activates the Nek6 and Nek7 kinases.
|
|
124.
|
2002
|
|
Fyn tyrosine kinase is a downstream mediator of Rho/PRK2 function in keratinocyte cell-cell adhesion.
|
|
125.
|
2001
|
|
Surfactant protein D (SP-D) and systemic scleroderma (SSc).
|
|
126.
|
2000
|
|
An experience for ELISA for desmoglein 1, suggesting a possible diagnostic help to determine the initial therapy for pemphigus foliaceus.
|
|
127.
|
2000
|
|
Assembly pathway of desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy.
|
|
128.
|
2000
|
|
Scraped-wounding causes activation and association of C-Src tyrosine kinase with microtubules in cultured keratinocytes.
|
|
129.
|
1999
|
|
A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes.
|
|
130.
|
1999
|
|
Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells.
|
|
131.
|
1995
|
|
Involvement of protein kinase C in bradykinin-induced intracellular calcium increase in primary cultured human keratinocytes.
|
|
Display 5 items
|
|
Display all(131)
|
